FR2721030B1 - Compounds modifying serotonergic transmission; diagnostic and therapeutic applications. - Google Patents

Compounds modifying serotonergic transmission; diagnostic and therapeutic applications.

Info

Publication number
FR2721030B1
FR2721030B1 FR9407079A FR9407079A FR2721030B1 FR 2721030 B1 FR2721030 B1 FR 2721030B1 FR 9407079 A FR9407079 A FR 9407079A FR 9407079 A FR9407079 A FR 9407079A FR 2721030 B1 FR2721030 B1 FR 2721030B1
Authority
FR
France
Prior art keywords
diagnostic
therapeutic applications
compounds modifying
serotonergic transmission
serotonergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9407079A
Other languages
French (fr)
Other versions
FR2721030A1 (en
Inventor
Gilles Fillion
Jean-Claude Rousselle
Olivier Massot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9407079A priority Critical patent/FR2721030B1/en
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to PCT/FR1994/001158 priority patent/WO1995009868A1/en
Priority to AT94929577T priority patent/ATE211483T1/en
Priority to DE69429582T priority patent/DE69429582T2/en
Priority to DK94929577T priority patent/DK0722457T3/en
Priority to KR1019960701742A priority patent/KR960704921A/en
Priority to CA002173460A priority patent/CA2173460A1/en
Priority to JP7510646A priority patent/JPH09503220A/en
Priority to EP94929577A priority patent/EP0722457B1/en
Priority to PT94929577T priority patent/PT722457E/en
Priority to US08/624,618 priority patent/US6713443B1/en
Priority to AU78579/94A priority patent/AU678298B2/en
Priority to ES94929577T priority patent/ES2170105T3/en
Publication of FR2721030A1 publication Critical patent/FR2721030A1/en
Application granted granted Critical
Publication of FR2721030B1 publication Critical patent/FR2721030B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR9407079A 1993-10-04 1994-06-09 Compounds modifying serotonergic transmission; diagnostic and therapeutic applications. Expired - Fee Related FR2721030B1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR9407079A FR2721030B1 (en) 1994-06-09 1994-06-09 Compounds modifying serotonergic transmission; diagnostic and therapeutic applications.
US08/624,618 US6713443B1 (en) 1993-10-04 1994-10-04 Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications
DE69429582T DE69429582T2 (en) 1993-10-04 1994-10-04 COMPOUNDS THAT AFFECT SEROTON INNER TRANSMISSION; YOUR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
DK94929577T DK0722457T3 (en) 1993-10-04 1994-10-04 Compounds that modify the serotoninergic transmission, and diagnostic and therapeutic use of such compounds
KR1019960701742A KR960704921A (en) 1993-10-04 1994-10-04 Compounds that Modulate Serotonin Delivery and Their Diagnostic and Therapeutic Uses
CA002173460A CA2173460A1 (en) 1993-10-04 1994-10-04 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
PCT/FR1994/001158 WO1995009868A1 (en) 1993-10-04 1994-10-04 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
EP94929577A EP0722457B1 (en) 1993-10-04 1994-10-04 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
PT94929577T PT722457E (en) 1993-10-04 1994-10-04 MODIFICATION COMPOUNDS FOR SEROTONINERGIC TRANSMISSION APPLICATIONS IN DIAGNOSIS AND THERAPY
AT94929577T ATE211483T1 (en) 1993-10-04 1994-10-04 COMPOUNDS THAT AFFECT SEROTONINERGIC TRANSMISSION; THEIR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
AU78579/94A AU678298B2 (en) 1993-10-04 1994-10-04 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
ES94929577T ES2170105T3 (en) 1993-10-04 1994-10-04 COMPOUNDS THAT MODIFY SEROTONINERGIC TRANSMISSION; DIAGNOSTIC AND THERAPEUTIC APPLICATIONS.
JP7510646A JPH09503220A (en) 1993-10-04 1994-10-04 Compounds that regulate serotonin transmission, diagnostic and therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9407079A FR2721030B1 (en) 1994-06-09 1994-06-09 Compounds modifying serotonergic transmission; diagnostic and therapeutic applications.

Publications (2)

Publication Number Publication Date
FR2721030A1 FR2721030A1 (en) 1995-12-15
FR2721030B1 true FR2721030B1 (en) 1996-08-30

Family

ID=9464053

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9407079A Expired - Fee Related FR2721030B1 (en) 1993-10-04 1994-06-09 Compounds modifying serotonergic transmission; diagnostic and therapeutic applications.

Country Status (1)

Country Link
FR (1) FR2721030B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5647895B2 (en) * 1973-06-08 1981-11-12
AU545416B2 (en) * 1979-04-06 1985-07-11 Carlsberg Biotechnology Ltd. A/S A process for enzymatic production of peptides
SE8803847A0 (en) * 1988-10-27 1990-04-28 Kabigen Ab Neuromodulatory peptide
FR2657784A1 (en) * 1990-02-05 1991-08-09 Pasteur Institut CEREBRAL ENDOGENIC FACTOR, PROCESS FOR OBTAINING THERAPEUTIC AND DIAGNOSTIC APPLICATIONS.
JPH0421635A (en) * 1990-05-16 1992-01-24 Suntory Ltd Toxicity-suppressing agent of acetaldehyde and drink and food effective in suppression of toxicity of acetaldehyde

Also Published As

Publication number Publication date
FR2721030A1 (en) 1995-12-15

Similar Documents

Publication Publication Date Title
DE69503593D1 (en) Transmission fluids
DE69723588D1 (en) Nurse / patient communication process
DE69428186D1 (en) Multiple transmission facility
DE69522243D1 (en) STILL REACTOR
DE59504565D1 (en) TRANSMISSION CASE
FI970531A (en) Blood lipid-lowering 1,4-benzothiazepine-1,1-dioxides
DE69606550D1 (en) MEDICAL CONNECTION ARRANGEMENT
KR960702892A (en) CLUTCH
ATA151095A (en) CLUTCH
DE59505514D1 (en) GEARBOX TRANSMISSION
FR2716375B3 (en) Medical injector.
DE69411073D1 (en) Medical bleach
ATA172195A (en) CLUTCH
BR9508589A (en) Improved transmission
FI951655A (en) Treatment of H. pylori infections
IT232371Y1 (en) DENTAL EQUIPMENT.
FR2721030B1 (en) Compounds modifying serotonergic transmission; diagnostic and therapeutic applications.
FR2721029B1 (en) Compounds modifying serotonergic transmission; diagnostic and therapeutic applications.
DE69520119D1 (en) Drawn agricultural equipment
KR960009993U (en) Improved home sauna
FR2716759B1 (en) Optimized operand formatting stage.
FR2717696B1 (en) Double-hole syringe.
KR950022790U (en) Medical bedding
DE69507258D1 (en) clutch
FI942023A (en) Rotary motion transmission clutch

Legal Events

Date Code Title Description
ST Notification of lapse